Also found in: Acronyms.
AMROAMsterdam-ROtterdam trial comparing excimer laser & PTCA. A clinical trial comparing two strategies for managing patients with stable angina and coronary lesions of native arteries ≥10 mm on visual assessment, including total or functional occlusions.
Primary endpoints Major acute coronary events (MACE)
Conclusion AMRO indicates that excimer laser coronary angioplasty (ELCA) yields no additional benefit in long coronary lesions; ELCA may be optimal for long, >20 mm lesions, aorta-ostial lesions, and total occlusions.